-
17187-250A ferric porphyrin complex that causes the decomposition of peroxynitrite by catalytic isomerization to produce nitrate both in vitro and in vivo, resulting in cytoprotection (EC<sub>50</sub> = 5 µM).
-
17187-50A ferric porphyrin complex that causes the decomposition of peroxynitrite by catalytic isomerization to produce nitrate both in vitro and in vivo, resulting in cytoprotection (EC<sub>50</sub> = 5 µM).
-
17369-1A selective FXR agonist (EC<sub>50</sub> = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 (EC<sub>50</sub> = 80 nM).
-
17369-10A selective FXR agonist (EC<sub>50</sub> = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 (EC<sub>50</sub> = 80 nM).
-
17369-5A selective FXR agonist (EC<sub>50</sub> = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 (EC<sub>50</sub> = 80 nM).
-
17369-50A selective FXR agonist (EC<sub>50</sub> = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 (EC<sub>50</sub> = 80 nM).
-
18393-1An antiparasitic drug that, in different preparations, is effective against trypanosomes orally available and rapidly metabolized to two active metabolites.
-
18393-10An antiparasitic drug that, in different preparations, is effective against trypanosomes orally available and rapidly metabolized to two active metabolites.
-
18393-25An antiparasitic drug that, in different preparations, is effective against trypanosomes orally available and rapidly metabolized to two active metabolites.
-
18393-5An antiparasitic drug that, in different preparations, is effective against trypanosomes orally available and rapidly metabolized to two active metabolites.
-
18191-10A non-sedating antihistamine that selectively antagonizes the histamine H1 receptor with a Ki value of 10 nM and exhibits anti-inflammatory effects.
-
18191-100A non-sedating antihistamine that selectively antagonizes the histamine H1 receptor with a Ki value of 10 nM and exhibits anti-inflammatory effects.